Metabolic Reprogramming and Predominance of Solute Carrier Genes during Acquired Enzalutamide Resistance in Prostate Cancer

Androgen deprivation therapy (ADT) is standard-of-care for advanced-stage prostate cancer, and enzalutamide (Xtandi(®), Astellas, Northbrook, IL, USA), a second generation antiandrogen, is prescribed in this clinical setting. The response to this medication is usually temporary with the rapid emerge...

Descripción completa

Detalles Bibliográficos
Autores principales: Verma, Shiv, Shankar, Eswar, Chan, E. Ricky, Gupta, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759897/
https://www.ncbi.nlm.nih.gov/pubmed/33255236
http://dx.doi.org/10.3390/cells9122535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759897/
https://www.ncbi.nlm.nih.gov/pubmed/33255236
http://dx.doi.org/10.3390/cells9122535

Ejemplares similares